196 related articles for article (PubMed ID: 18794111)
1. Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines.
Lopes EC; Valls E; Figueroa ME; Mazur A; Meng FG; Chiosis G; Laird PW; Schreiber-Agus N; Greally JM; Prokhortchouk E; Melnick A
Cancer Res; 2008 Sep; 68(18):7258-63. PubMed ID: 18794111
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
Yu J; Ma X; Cheung KF; Li X; Tian L; Wang S; Wu CW; Wu WK; He M; Wang M; Ng SS; Sung JJ
Oncogene; 2010 Dec; 29(49):6464-74. PubMed ID: 20802524
[TBL] [Abstract][Full Text] [Related]
3. Kaiso represses the cell cycle gene cyclin D1 via sequence-specific and methyl-CpG-dependent mechanisms.
Donaldson NS; Pierre CC; Anstey MI; Robinson SC; Weerawardane SM; Daniel JM
PLoS One; 2012; 7(11):e50398. PubMed ID: 23226276
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
5. MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells.
Martin V; Jørgensen HF; Chaubert AS; Berger J; Barr H; Shaw P; Bird A; Chaubert P
Pathobiology; 2008; 75(5):281-7. PubMed ID: 18931530
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
7. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
8. KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes.
Koh DI; Han D; Ryu H; Choi WI; Jeon BN; Kim MK; Kim Y; Kim JY; Parry L; Clarke AR; Reynolds AB; Hur MW
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15078-83. PubMed ID: 25288747
[TBL] [Abstract][Full Text] [Related]
9. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA
Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557
[TBL] [Abstract][Full Text] [Related]
10. FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.
Asada K; Ando T; Niwa T; Nanjo S; Watanabe N; Okochi-Takada E; Yoshida T; Miyamoto K; Enomoto S; Ichinose M; Tsukamoto T; Ito S; Tatematsu M; Sugiyama T; Ushijima T
Oncogene; 2013 Apr; 32(17):2140-9. PubMed ID: 22689052
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2.
McGarvey KM; Greene E; Fahrner JA; Jenuwein T; Baylin SB
Cancer Res; 2007 Jun; 67(11):5097-102. PubMed ID: 17545586
[TBL] [Abstract][Full Text] [Related]
12. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
14. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers.
Ying J; Poon FF; Yu J; Geng H; Wong AH; Qiu GH; Goh HK; Rha SY; Tian L; Chan AT; Sung JJ; Tao Q
Br J Cancer; 2009 Feb; 100(4):663-9. PubMed ID: 19156137
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic effects of inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer.
Nagaraju GP; Wu C; Merchant N; Chen Z; Lesinski GB; El-Rayes BF
Cancer Lett; 2017 Aug; 402():110-116. PubMed ID: 28583846
[TBL] [Abstract][Full Text] [Related]
16. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
17. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
[TBL] [Abstract][Full Text] [Related]
18. Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma.
Healey MA; Deaton SL; Alder JK; Winnepenninckx V; Casero RA; Herman JG
Epigenetics; 2010 Jul; 5(5):410-21. PubMed ID: 20484992
[TBL] [Abstract][Full Text] [Related]
19. Synergism between DNA methylation and macroH2A1 occupancy in epigenetic silencing of the tumor suppressor gene p16(CDKN2A).
Barzily-Rokni M; Friedman N; Ron-Bigger S; Isaac S; Michlin D; Eden A
Nucleic Acids Res; 2011 Mar; 39(4):1326-35. PubMed ID: 21030442
[TBL] [Abstract][Full Text] [Related]
20. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor.
Prokhortchouk A; Hendrich B; Jørgensen H; Ruzov A; Wilm M; Georgiev G; Bird A; Prokhortchouk E
Genes Dev; 2001 Jul; 15(13):1613-8. PubMed ID: 11445535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
